Company Quick10K Filing
Quick10K
Schmitt Industries
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$2.21 4 $9
10-Q 2019-02-28 Quarter: 2019-02-28
10-Q 2018-11-30 Quarter: 2018-11-30
10-Q 2018-08-31 Quarter: 2018-08-31
10-K 2018-05-31 Annual: 2018-05-31
10-Q 2018-02-28 Quarter: 2018-02-28
10-Q 2017-11-30 Quarter: 2017-11-30
10-Q 2017-08-31 Quarter: 2017-08-31
10-K 2017-05-31 Annual: 2017-05-31
10-Q 2017-02-28 Quarter: 2017-02-28
10-Q 2016-11-30 Quarter: 2016-11-30
10-Q 2016-08-31 Quarter: 2016-08-31
10-K 2016-05-31 Annual: 2016-05-31
10-Q 2016-02-29 Quarter: 2016-02-29
10-Q 2015-11-30 Quarter: 2015-11-30
10-Q 2015-08-31 Quarter: 2015-08-31
10-K 2015-05-31 Annual: 2015-05-31
10-Q 2015-02-28 Quarter: 2015-02-28
10-Q 2014-11-30 Quarter: 2014-11-30
10-Q 2014-08-31 Quarter: 2014-08-31
10-K 2014-05-31 Annual: 2014-05-31
10-Q 2014-02-28 Quarter: 2014-02-28
10-Q 2013-11-30 Quarter: 2013-11-30
8-K 2019-07-31 Earnings, Other Events, Exhibits
8-K 2019-07-30 Enter Agreement, Officers, Exhibits
8-K 2019-07-01 Enter Agreement, Shareholder Rights, Amend Bylaw, Regulation FD, Exhibits
8-K 2019-06-21 Officers, Exhibits
8-K 2019-04-10 Earnings, Exhibits
8-K 2019-01-10 Earnings, Exhibits
8-K 2018-12-18
8-K 2018-11-26 Enter Agreement, Officers, Amend Bylaw, Exhibits
8-K 2018-10-30 Enter Agreement, Exhibits
8-K 2018-10-16 Shareholder Vote
8-K 2018-10-12 Earnings, Exhibits
8-K 2018-09-14 Other Events, Exhibits
8-K 2018-07-18 Earnings, Officers, Exhibits
8-K 2018-04-06 Earnings, Exhibits
8-K 2018-01-05 Officers, Exhibits
HSBC Hsbc Holdings 173,140
CMPR Cimpress 2,760
RPD Rapid7 2,550
KBH KB Home 2,250
NCI Navigant Consulting 884
EVFM Evofem Biosciences 203
STDY Steadymed 0
ATMS Artemis Therapeutics 0
RLMD Relmada Therapeutics 0
CSBB CSB Bancorp 0
SMIT 2019-02-28
Part I - Financial Information
Item 1. Financial Statements
Note 1:
Note 2:
Note 3:
Note 4:
Note 5:
Note 6:
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 6. Exhibits
EX-31.1 d688702dex311.htm
EX-31.2 d688702dex312.htm
EX-32.1 d688702dex321.htm

Schmitt Industries Earnings 2019-02-28

SMIT 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

10-Q 1 d688702d10q.htm 10-Q 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: February 28, 2019

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from:                      To:                     

Commission File Number: 000-23996

 

 

SCHMITT INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Oregon   93-1151989

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification Number)

2765 NW Nicolai Street, Portland, Oregon 97210-1818

(Address of principal executive offices) (Zip Code)

(503) 227-7908

 

 

Indicate by check mark whether the registrant has (1) filed all reports required to be filed by Section 13 of 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
Emerging growth company       

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The number of shares of each class of common stock outstanding as of March 31, 2019

 

Common stock, no par value

     4,032,878  

 

 

 


Table of Contents

SCHMITT INDUSTRIES, INC.

INDEX TO FORM 10-Q

 

          Page  

Part I - FINANCIAL INFORMATION

  

Item 1.

   Consolidated Financial Statements (unaudited):   
   Consolidated Balance Sheets      3  
   Consolidated Statements of Operations and Comprehensive Income (Loss)      4  
   Consolidated Statements of Cash Flows      5  
   Consolidated Statement of Changes in Stockholders’ Equity      6  
   Notes to Consolidated Interim Financial Statements      7  

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations      15  

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk      20  

Item 4.

   Controls and Procedures      20  

Part II - OTHER INFORMATION

  

Item 1.

   Legal Proceedings      21  

Item 6.

   Exhibits      21  

Signatures

     22  

Certifications

  

 

 

Page 2


Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

SCHMITT INDUSTRIES, INC.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

     February 28, 2019     May 31, 2018  
ASSETS

 

Current assets

    

Cash and cash equivalents

   $ 1,168,930     $ 2,053,181  

Restricted cash

     56,835       58,352  

Accounts receivable, net

     2,078,116       2,047,032  

Inventories

     5,751,164       5,710,888  

Prepaid expenses

     193,326       148,924  

Income taxes receivable

     206       0  
  

 

 

   

 

 

 

Total current assets

     9,248,577       10,018,377  
  

 

 

   

 

 

 

Property and equipment, net

     863,361       770,915  
  

 

 

   

 

 

 

Other assets

    

Intangible assets, net

     418,331       496,768  
  

 

 

   

 

 

 

TOTAL ASSETS

   $  10,530,269     $  11,286,060  
  

 

 

   

 

 

 
LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current liabilities

    

Accounts payable

   $ 977,436     $ 1,024,256  

Accrued commissions

     194,943       194,797  

Accrued payroll liabilities

     192,953       188,568  

Other accrued liabilities

     437,209       358,790  

Income taxes payable

     0       3,993  

Current portion of long-term liabilities

     21,424       0  
  

 

 

   

 

 

 

Total current liabilities

     1,823,965       1,770,404  
  

 

 

   

 

 

 

Long-term liabilities

     35,601       0  
  

 

 

   

 

 

 

Stockholders’ equity

    

Common stock, no par value, 20,000,000 shares authorized, 4,032,878 shares issued and outstanding at February 28, 2019 and 3,994,545 shares issued and outstanding at May 31, 2018

     13,156,496       13,085,652  

Accumulated other comprehensive loss

     (509,826     (536,307

Accumulated deficit

     (3,975,967     (3,033,689
  

 

 

   

 

 

 

Total stockholders’ equity

     8,670,703       9,515,656  
  

 

 

   

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 10,530,269     $ 11,286,060  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 3


Table of Contents

SCHMITT INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE THREE AND NINE MONTHS ENDED FEBRUARY 28, 2019 AND 2018

(UNAUDITED)

 

     Three Months Ended February 28,     Nine Months Ended February 28,  
     2019     2018     2019     2018  

Net sales

   $  3,082,181     $  3,238,858     $  10,026,112     $  10,093,386  

Cost of sales

     2,069,798       1,916,345       6,310,824       5,645,372  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     1,012,383       1,322,513       3,715,288       4,448,014  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

General, administration and sales

     1,507,233       1,286,718       4,452,091       4,279,505  

Research and development

     20,532       75,790       116,693       253,007  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,527,765       1,362,508       4,568,784       4,532,512  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating loss

     (515,382     (39,995     (853,496     (84,498

Other income (expense), net

     46,779       61,815       (69,468     88,436  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     (468,603     21,820       (922,964     3,938  

Provision for income taxes

     6,586       6,267       19,314       19,235  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (475,189)     $ 15,553     $ (942,278)     $ (15,297)  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per common share:

        

Basic

   $ (0.12   $ 0.00     $ (0.24   $ 0.00  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares, basic

     4,000,990       3,706,050       3,996,670       3,230,022  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

   $ (0.12   $ 0.00     $ (0.24   $ 0.00  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares, diluted

     4,000,990       3,769,814       3,996,670       3,230,022  
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income (loss)

        

Net income (loss)

   $ (475,189   $ 15,553     $ (942,278   $ (15,297

Foreign currency translation adjustment

     (47,256     (51,983     26,481       (51,543
  

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income (loss)

   $ (522,445   $ (36,430   $ (915,797   $ (66,840
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 4


Table of Contents

SCHMITT INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED FEBRUARY 28, 2019 AND 2018

(UNAUDITED)

 

     Nine Months Ended February 28,  
     2019     2018  

Cash flows relating to operating activities

    

Net loss

   $  (942,278   $ (15,297

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization

     139,424       156,326  

(Gain) loss on disposal of property and equipment

     0       619  

Stock based compensation

     5,678       42,167  

Reserve for excess or obsolete inventories

     407,730       0  

(Increase) decrease in:

    

Accounts receivable

     (30,061     291,273  

Inventories

     (447,717     (1,218,520

Prepaid expenses

     (44,503     (32,086

Income taxes receivable

     (206     7,310  

Increase (decrease) in:

    

Accounts payable

     (46,263     (261,532

Accrued liabilities and customer deposits

     (77     (69,917

Income taxes payable

     (3,993     3,465  
  

 

 

   

 

 

 

Net cash used in operating activities

     (962,266     (1,096,192
  

 

 

   

 

 

 

Cash flows relating to investing activities

    

Purchases of property and equipment

     (4,674     (8,467

Proceeds from the sale of property and equipment

     0       1,500  
  

 

 

   

 

 

 

Net cash used in investing activities

     (4,674     (6,967
  

 

 

   

 

 

 

Cash flows relating to financing activities

    

Payments on long-term liabilities

     (8,366     0  

Common stock issued on exercise of stock options

     65,166       0  

Proceeds from the rights offering, net of expenses

     0       2,386,029  
  

 

 

   

 

 

 

Net cash provided by financing activities

     56,800       2,386,029  
  

 

 

   

 

 

 

Effect of foreign exchange translation on cash

     24,372       (103,507
  

 

 

   

 

 

 

Change in cash, cash equivalents and restricted cash

     (885,768     1,179,363  

Cash, cash equivalents and restricted cash, beginning of period

     2,111,533       867,607  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $  1,225,765     $ 2,046,970  
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information

    

Cash paid during the period for income taxes

   $ 23,512     $ 8,460  
  

 

 

   

 

 

 

Cash paid during the period for interest

   $ 8,985     $ 1,114  
  

 

 

   

 

 

 

Supplemental disclosure of non-cash investing and financing activities

    

Acquisition of property and equipment through financed payables

   $ 148,760     $ 0  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 5


Table of Contents

SCHMITT INDUSTRIES, INC.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE NINE MONTHS ENDED FEBRUARY 28, 2019

(UNAUDITED)

 

     Shares      Amount      Accumulated
other
comprehensive
loss
    Accumulated
deficit
    Total  

Balance, May 31, 2018

     3,994,545      $  13,085,652      $  (536,307   $  (3,033,689   $  9,515,656  

Stock options exercised net of related tax benefit of $0

     38,333        65,166        0       0       65,166  

Stock-based compensation

     0        5,678        0       0       5,678  

Net loss

     0        0        0       (942,278     (942,278

Other comprehensive income

     0        0        26,481       0       26,481  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Balance, February 28, 2019

     4,032,878      $ 13,156,496      $  (509,826   $  (3,975,967   $ 8,670,703  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these financial statements.

 

Page 6


Table of Contents

SCHMITT INDUSTRIES, INC.

NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS

NOTE 1:

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial information included herein has been prepared by Schmitt Industries, Inc. (the “Company” or “Schmitt”) and its wholly owned subsidiaries. In the opinion of management, the accompanying unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and contain all adjustments, consisting only of normal recurring adjustments, necessary to present fairly its financial position as of February 28, 2019 and its results of operations and its cash flows for the periods presented. The consolidated balance sheet at May 31, 2018 has been derived from the Annual Report on Form 10-K for the fiscal year ended May 31, 2018. The accompanying unaudited financial statements and related notes should be read in conjunction with the audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2018. Operating results for the interim periods presented are not necessarily indicative of the results that may be experienced for the fiscal year ending May 31, 2019.

Revenue Recognition

On June 1, 2018, the Company adopted Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” using the modified retrospective approach. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements or related disclosures.

The Company determines the amount of revenue it recognizes associated with the transfer of each product or service using the five-step model provided by Topic 606. For sales of products or delivery of monitoring services to all customers, including manufacturing representatives, distributors or their third-party customers, each transaction is evaluated to determine whether there is approval and commitment from both the Company and the customer for the transaction; whether the rights of each party are specifically identified; whether the transaction has commercial substance; whether collectability from the customer is probable at the inception of the contract and whether the transaction amount is defined. If a transaction to sell products or provide monitoring services meets all of the above criteria, revenue is recognized for the sales of product at the time of shipment or for monitoring services at the completion of the month in which monitoring services are provided.

The Company incurs commissions associated with the sales of products, which are accrued and expensed at the time the product is shipped. These amounts are recorded within general, administration and sales expense.

The Company also incurs costs related to shipping and handling of its products, the costs of which are expensed as incurred as a component of cost of sales. Shipping and handling fees billed to customers are recognized at the time of shipment as a component of net sales.

Financial Instruments

The carrying value of all other financial instruments potentially subject to valuation risk (principally consisting of cash and cash equivalents, accounts receivable and accounts payable) also approximates fair value because of their short-term maturities.

Restricted Cash

Restricted cash consists of an amount received from a customer in December 2017 as part of an on-going contract. The timeline for services being provided under this contract has been extended and is expected to be completed during the second half of Fiscal 2019, at which time the restrictions on this payment will lapse.

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the Consolidated Balance Sheets as of February 28, 2019 and May 31, 2018 to the sum of the same such amounts as shown in the Consolidated Statement of Cash Flows for the nine months ended February 28, 2019:

 

Page 7


Table of Contents
     February 28, 2019      May 31, 2018  

Cash and cash equivalents

   $ 1,168,930      $ 2,053,181  

Restricted cash

     56,835        58,352  
  

 

 

    

 

 

 

Total cash, cash equivalents, and restricted cash shown in the Consolidated Statement of Cash Flows

   $ 1,225,765      $ 2,111,533  
  

 

 

    

 

 

 

Accounts Receivable

The Company maintains credit limits for all customers based upon several factors, including but not limited to financial condition and stability, payment history, published credit reports and use of credit references. Management performs various analyses to evaluate accounts receivable balances to ensure recorded amounts reflect estimated net realizable value. This review includes using accounts receivable agings, other operating trends and relevant business conditions, including general economic factors, as they relate to each of the Company’s domestic and international customers. If these analyses lead management to the conclusion that potential significant accounts are uncollectible, a reserve is provided. The allowance for doubtful accounts was $26,263 and $95,207 as of February 28, 2019 and May 31, 2018, respectively.

Inventories

Inventories are valued at the lower of cost or net realizable value with cost determined on the average cost basis. Costs included in inventories consist of materials, labor and manufacturing overhead, which are related to the purchase or production of inventories. Write-downs, when required, are made to reduce excess inventories to their net realizable values. Such estimates are based on assumptions regarding future demand and market conditions. If actual conditions become less favorable than the assumptions used, an additional inventory write-down may be required. As of February 28, 2019 and May 31, 2018, inventories consisted of:

 

     February 28, 2019      May 31, 2018  

Raw materials

   $ 2,411,474      $ 2,796,691  

Work-in-process

     1,056,251        1,009,424  

Finished goods

     2,283,439        1,904,773  
  

 

 

    

 

 

 
   $ 5,751,164      $ 5,710,888  
  

 

 

    

 

 

 

Inventories, as noted in the above table and on the Consolidated Balance Sheets as of February 28, 2019 and May 31, 2018, are presented net of inventory reserves of $1,150,597 and $742,900 as of February 28, 2019 and May 31, 2018.

Reserve adjustments of $(407,558) and $(6,555) for the three months ended February 28, 2019 and 2018, respectively, are included in cost of sales on the Consolidated Statements of Operations. Reserve adjustments of $(407,730) and $11,035 for the nine months ended February 28, 2019 and 2018, respectively, are included in cost of sales on the Consolidated Statements of Operations.

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over estimated useful lives of three to seven years for furniture, fixtures and equipment; three years for vehicles; and twenty-five years for buildings and improvements. As of February 28, 2019 and May 31, 2018, property and equipment consisted of:

 

Page 8


Table of Contents
     February 28, 2019      May 31, 2018  

Land

   $ 299,000      $ 299,000  

Buildings and improvements

     1,814,524        1,814,524  

Furniture, fixtures and equipment

     1,406,725        1,252,598  

Vehicles

     44,704        44,704  
  

 

 

    

 

 

 
     3,564,953        3,410,826  

Less accumulated depreciation

     (2,701,592      (2,639,911
  

 

 

    

 

 

 
   $ 863,361      $ 770,915  
  

 

 

    

 

 

 

Long-term liabilities and current portion of long-term liabilities

Long-term liabilities consist of a financing arrangement executed for the purchase of certain property and equipment over a term of 36 months. Future minimum commitments under this agreement for the each of the years ending May 31 are as follows:

 

     Years ending May 31,  

2019

   $ 4,218  

2020

     25,307  

2021

     25,307  

2022

     8,431  
  

 

 

 

Total future minimum payments

     63,263  

Less: amount representing interest

     (6,238
  

 

 

 

Present value of minimum payments of long-term liabilities

   $ 57,025  
  

 

 

 

Current portion of long-term liabilities

     21,424  

Long-term liabilities

     35,601  
  

 

 

 
   $ 57,025  
  

 

 

 

Recent Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for most leases previously classified as operating leases. The ASU is required to be applied using a modified retrospective approach at the beginning of the earliest period presented, with optional practical expedients. The FASB recently proposed an optional transition alternative, which would allow for application of the guidance at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period presented. The Company will adopt the new standard on June 1, 2019.

The Company is currently evaluating the impact of this guidance, including reviewing the standard’s provisions and gathering and analyzing data to support further evaluation of all real estate and non-real estate leases. The Company is also evaluating the impact of the accounting standard on the Company’s financial statement disclosures, systems, processes and controls.

NOTE 2:

STOCK OPTIONS AND STOCK-BASED COMPENSATION

Stock-based compensation includes expense charges for all stock-based awards to employees and directors granted under the Company’s stock option plan. Stock-based compensation recognized during the period is based on the portion of the grant date fair value of the stock-based award that will vest during the period, adjusted for expected forfeitures. Compensation cost for all stock-based awards is recognized using the straight-line method. The Company uses the Black-Scholes option pricing model as its method of valuation for stock-based awards. The Black-Scholes option pricing model requires the input of highly subjective assumptions, and other reasonable assumptions could provide differing results. These variables include, but are not limited to:

 

Page 9


Table of Contents
   

Risk-Free Interest Rate. The Company bases the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award.

 

   

Expected Life. The expected life of awards granted represents the period of time that they are expected to be outstanding. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and pre-vesting and post-vesting forfeitures.

 

   

Expected Volatility. The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of its common stock. The volatility factor the Company uses is based on its historical stock prices over the most recent period commensurate with the estimated expected life of the award. These historical periods may exclude portions of time when unusual transactions occurred.

 

   

Expected Dividend Yield. The Company does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of 0.

 

   

Expected Forfeitures. The Company uses relevant historical data to estimate pre-vesting option forfeitures. The Company records stock-based compensation only for those awards that are expected to vest.

To determine stock-based compensation expense recognized for those options granted during the nine months ended February 28, 2019, the Company has computed the value of all stock options granted using the Black-Scholes option pricing model as prescribed by ASC Topic 718 using the following assumptions:

 

     Nine Months Ended
     February 28, 2019

Risk-free interest rate

   3.1%

Expected life

   6.0 years

Expected volatility

   46.3%

At February 28, 2019, the Company had a total of 266,166 outstanding stock options (243,665 vested and exercisable and 22,501 non-vested) with a weighted average exercise price of $2.42. The Company estimates that $897 will be recorded as additional stock-based compensation expense during the next fiscal quarter for all options that were outstanding as of February 28, 2019, but which were not yet vested.

 

Outstanding Options      Exercisable Options  
Number of
Shares
     Weighted Average
Exercise Price
     Weighted Average
Remaining Contractual
Life (yrs)
     Number of Shares      Weighted Average
Exercise Price
 
  124,166      $ 1.70        8.1        101,665      $ 1.70  
  15,000        2.53        4.6        15,000        2.53  
  82,000        2.82        5.8        82,000        2.82  
  45,000        3.65        2.3        45,000        3.65  

 

 

          

 

 

    
  266,166        2.42        6.2        243,665        2.49  

 

 

          

 

 

    

Options granted, exercised, and forfeited or canceled under the Company’s stock option plan during the nine months ended February 28, 2019 are summarized as follows:

 

Page 10


Table of Contents
     Nine Months Ended
February 28, 2019
 
     Number of
Shares
     Weighted
Average
Exercise Price
 

Options outstanding - beginning of period

     318,332      $ 2.36  

Options granted

     27,000        2.55  

Options exercised

     (38,333      1.70  

Options forfeited/canceled

     (40,833      2.66  
  

 

 

    

Options outstanding - end of period

     266,166        2.42  
  

 

 

    

NOTE 3:

WEIGHTED AVERAGE SHARES AND RECONCILIATION

 

     Three Months Ended
February 28,
     Nine Months Ended
February 28,
 
     2019      2018      2019      2018  

Weighted average shares (basic)

     4,000,990        3,706,050        3,996,670        3,230,022  

Effect of dilutive stock options

     0        63,764        0        0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average shares (diluted)

     4,000,990        3,769,814        3,996,670        3,230,022  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding, adjusted for dilutive incremental shares attributed to outstanding options to purchase common stock. Common stock equivalents for stock options are computed using the treasury stock method. In periods in which a net loss is incurred, no common stock equivalents are included since they are antidilutive and as such all stock options outstanding are excluded from the computation of diluted net loss in those periods.

NOTE 4:

INCOME TAXES

The Company accounts for income taxes using the asset and liability method. This approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Management continues to review the level of the valuation allowance on a quarterly basis. There can be no assurance that the Company’s future operations will produce sufficient earnings to allow for the deferred tax asset to be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets.

Each year the Company files income tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the taxing authorities. Positions challenged by the taxing authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with ASC Topic 740. The Company applies this guidance by defining criteria that an individual income tax position must meet for any part of the benefit of that position to be recognized in an enterprise’s financial statements and provides guidance on measurement, de-recognition, classification, accounting for interest and penalties, accounting in interim periods, disclosure, and transition.

Other long-term liabilities related to tax contingencies were $0 as of February 28, 2019 and May 31, 2018. Interest and penalties associated with uncertain tax positions are recognized as components of the “Provision for income taxes.” The liability for payment of interest and penalties was $0 as of February 28, 2019 and May 31, 2018.

 

Page 11


Table of Contents

Several tax years are subject to examination by major tax jurisdictions. In the United States, federal tax years ended May 31, 2015 and after are subject to examination. In the United Kingdom, tax years ended May 31, 2013 and after are subject to examination.

Effective Tax Rate

The effective tax rate on consolidated net loss was 2.1% for the nine months ended February 28, 2019. The effective tax rate on consolidated net loss differs from the federal statutory tax rate primarily due to changes in the deferred tax valuation allowance and certain expenses not being deductible for income tax reporting purposes. Management believes the effective tax rate for Fiscal 2019 will be approximately 3.2% due to the items noted above.

NOTE 5:

SEGMENTS OF BUSINESS

The Company has two reportable business segments, Balancer and Measurement. Balancer focuses on dynamic balancing and process control systems for the machine tool industry and Measurement focuses on laser-based test and measurement systems and ultrasonic measurement products. The Company operates in three principal geographic markets: North America, Europe and Asia.

Segment Information

 

     Three Months Ended February 28,  
     2019      2018  
     Balancer      Measurement      Balancer      Measurement  

Net sales

   $ 1,961,636      $ 1,120,545      $ 2,137,811      $ 1,101,047  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss)

     $(593,462)      $ 78,080      $ (39,720)      $ (275)  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 10,346      $ 9,000      $ 16,300      $ 9,235  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 0      $ 26,145      $ 0      $ 26,146  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 147,917      $ 0      $ 0      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Nine Months Ended February 28,  
     2019      2018  
     Balancer      Measurement      Balancer      Measurement  

Net sales

   $ 6,501,448      $ 3,524,664      $ 6,439,054      $ 3,654,332  
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income (loss)

   $ (1,199,680)      $ 346,184      $ (340,486)      $ 255,988  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 33,989      $ 26,998      $ 49,670      $ 28,218  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 0      $ 78,437      $ 0      $ 78,438  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 153,434      $ 0      $ 8,467      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Inventory reserve adjustments of $(291,427) for the Balancer segment and $(116,131) for the Measurement segment are included in operating income (loss) for the three and nine months ended February 28, 2019, respectively.

 

Page 12


Table of Contents

Geographic Information – Net Sales by Geographic Area

 

     Three Months Ended February 28,      Nine Months Ended February 28,  
     2019      2018      2019      2018  

North America

   $ 1,899,961      $ 1,898,796      $ 6,065,868      $ 6,174,874  

Europe

     548,059        552,018        1,427,310        1,526,917  

Asia

     587,136        752,712        2,389,087        2,297,617  

Other markets

     47,025        35,332        143,847        93,978  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total net sales

   $ 3,082,181      $ 3,238,858      $ 10,026,112      $ 10,093,386  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Three Months Ended February 28,  
     2019      2018  
     United States (2)      Europe (1)      United States (2)      Europe (1)  

Operating income (loss)

   $ (565,426    $ 50,044      $ (123,205    $ 83,210  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 19,346      $ 0      $ 25,535      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 26,145      $ 0      $ 26,146      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 147,917      $ 0      $ 0      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Nine Months Ended February 28,  
     2019      2018  
     United States (2)      Europe (1)      United States (2)      Europe (1)  

Operating income (loss)

   $ (959,525)        106,029      $ (307,015)        222,517  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation expense

   $ 60,987      $ 0      $ 77,888      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Amortization expense

   $ 78,437      $ 0      $ 78,438      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

Capital expenditures

   $ 153,434      $ 0      $ 8,467      $ 0  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

“Europe” is defined in the above chart to include results from the European subsidiary, Schmitt Europe Ltd.

(2)

“United States” is defined to include remainder of the results not included in the European subsidiary.

Segment and Geographic Assets

 

     February 28, 2019      May 31, 2018  

Segment assets to total assets

     

Balancer

   $ 6,292,198      $ 6,461,974  

Measurement

     3,012,100        2,712,553  

Corporate assets

     1,225,971        2,111,533  
  

 

 

    

 

 

 

Total assets

   $ 10,530,269      $ 11,286,060  
  

 

 

    

 

 

 

Geographic assets to long-lived assets

     

United States (2)

   $ 863,361      $ 770,915  

Europe (1)

     0        0  
  

 

 

    

 

 

 

Total long-lived assets

   $ 863,361      $ 770,915  
  

 

 

    

 

 

 

Geographic assets to total assets

     

United States (2)

   $ 9,314,335      $ 10,110,683  

Europe (1)

     1,215,934        1,175,377  
  

 

 

    

 

 

 

Total assets

   $ 10,530,269      $ 11,286,060  
  

 

 

    

 

 

 

 

(1)

“Europe” includes assets held by the European subsidiary, Schmitt Europe Ltd.

(2)

“United States” includes remainder of the assets not held by the European subsidiary.

 

Page 13


Table of Contents

NOTE 6:

RESTRUCTURING AND RELATED CHARGES

In November 2018 Schmitt announced a strategic reorganization following the appointment of two new board members. The reorganization will position the Company to better capitalize on the growing SBS Balancer business while streamlining the company and maximizing shareholder value through the disposition of non-core assets. The reorganization has involved a streamlining of contractors and services, and employee severance and termination benefits that have increased operating expenses in the third quarter. In conjunction with these efforts, an inventory adjustment of $(407,558) was recorded during the three months ended February 28, 2019 that was the outcome of efforts to evaluate the types and levels of inventory maintained across the Company’s three product lines.

 

Page 14


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report filed with the SEC on Form 10-Q (the “Report”), including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Item 2, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding future events and the future results of Schmitt Industries, Inc. and its consolidated subsidiaries (the “Company”) that are based on management’s current expectations, estimates, projections and assumptions about the Company’s business. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “sees,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including, but not limited to, those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Report as well as those discussed from time to time in the Company’s other Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions. Such forward-looking statements speak only as of the date of this Report or, in the case of any document incorporated by reference, the date of that document, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Report. If we update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections with respect to other forward-looking statements.

RESULTS OF OPERATIONS

Overview

Schmitt Industries, Inc. (“Schmitt” or the “Company”) designs, manufactures and sells high precision test and measurement products, solutions and services. We provide the products and services through our SBS®, Acuity® and Xact® Product lines, which are reported in two business segments, Balancer and Measurement:

 

   

Balancer (“Balancer”) Segment. Through our SBS products, the Balancer segment designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the worldwide machine tool industry, particularly for grinding machines. The Company also provides sales and service for Europe and Asia through its wholly owned subsidiary, Schmitt Europe Limited (SEL), located in Coventry, England and through its sales representative office located in Shanghai, China.

 

   

Measurement (“Measurement”) Segment. The Measurement segment manufacturers and sells products in two core product lines, Acuity and Xact:

 

   

Acuity sells products, solutions and services that includes laser and white light sensor distance, measurement and dimensional sizing products;

 

   

Xact product line includes ultrasonic-based remote tank monitoring products and related monitoring revenues for markets in the Internet of Things (“IoT”) environment. The products and services measure the fill levels of tanks holding propane, diesel and other tank-based liquids and the related monitoring services, which includes transmission of fill data from the tanks via satellite to a secure web site for display.

The accompanying unaudited financial information should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended May 31, 2018.

Highlights of the Three and Nine Months Ended February 28, 2019

 

   

Balancer segment sales decreased $176,175, or 8.2%, to $1,961,636 for the three months ended February 28, 2019 as compared to $2,137,811 for the three months ended February 28, 2018. Balancer segment sales increased $62,394, or 1.0%, to $6,501,448 for the nine months ended February 28, 2019 as compared to $6,439,054 for the nine months ended February 28, 2018.

 

   

Measurement segment sales increased $19,498, or 1.8%, to $1,120,545 for the three months ended February 28, 2019 as compared to $1,101,047 for the three months ended February 28, 2018. Measurement segment sales decreased $129,668, or 3.5%, to $3,524,664 for the nine months ended February 28, 2019 as compared to $3,654,332 for the nine months ended February 28, 2018.

 

Page 15


Table of Contents
   

Within the Measurement segment, Xact monitoring revenues continued to grow, increasing 13.4% for the three months ended February 28, 2019 compared to the three months ended February 28, 2018. Xact monitoring revenues increased 15.7% for the nine months ended February 28, 2019 as compared to the same period in the prior year.

 

   

Operating expenses increased $165,257, or 12.1%, to $1,527,765 for the three months ended February 28, 2019 from $1,362,508 for the three months ended February 28, 2018, and increased $36,272, or 0.8%, to $4,568,784 for the nine months ended February 28, 2019 compared to $4,532,512 for the nine months ended February 28, 2018. These results include non-recurring reorganization, legal and other professional expenses of $292,888 and $637,447 incurred during the three-month and nine-month periods ended February 28, 2019, respectively, that were not incurred during the same periods in the prior year.

 

   

An inventory adjustment of $(407,558) was recorded during the three months ended February 28, 2019 that was the outcome of efforts to evaluate the types and levels of inventory maintained across the Company’s three product lines. This resulted in a direct adjustment to cost of sales, thereby reducing gross margin from 46.1% to 32.8% for the three months ended February 28, 2019 and from 41.1% to 37.1% for the nine months ended February 28, 2019.

Critical Accounting Policies

There were no material changes in our critical accounting policies as disclosed in our Annual Report on Form 10-K for the year ended May 31, 2018, other than the adoption of Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” which the Company adopted on June 1, 2018. See Note 1 “Revenue Recognition” for further discussion and disclosures related to the adoption of ASU No. 2014-09.

Discussion of Operating Results

 

     Three Months Ended  
     February 28, 2019     February 28, 2018  

Balancer sales

   $ 1,961,636        63.6   $ 2,137,811        66.0

Measurement sales

     1,120,545        36.4     1,101,047        34.0
  

 

 

      

 

 

    

Total net sales

     3,082,181        100.0     3,238,858        100.0

Cost of sales

     2,069,798        67.2     1,916,345        59.2
  

 

 

      

 

 

    

Gross profit

     1,012,383        32.8     1,322,513        40.8
  

 

 

      

 

 

    

Operating expenses:

          

General, administration and sales

     1,507,233        48.9     1,286,718        39.7

Research and development

     20,532        0.7     75,790        2.3
  

 

 

      

 

 

    

Total operating expenses

     1,527,765        49.6     1,362,508        42.1
  

 

 

      

 

 

    

Operating loss

     (515,382      (16.7 %)      (39,995      (1.2 %) 

Other income (expense), net

     46,779        1.5     61,815        1.9
  

 

 

      

 

 

    

Income (loss) before income taxes

     (468,603      (15.2 %)      21,820        0.7

Provision for income taxes

     6,586        0.2     6,267        0.2
  

 

 

      

 

 

    

Net income (loss)

   $ (475,189      (15.4 %)    $ 15,553        0.5
  

 

 

      

 

 

    

 

Page 16


Table of Contents
     Nine Months Ended  
     February 28, 2019     February 28, 2018  

Balancer sales

   $ 6,501,448        64.8   $ 6,439,054        63.8

Measurement sales

     3,524,664        35.2     3,654,332        36.2
  

 

 

      

 

 

    

Total net sales

     10,026,112        100.0     10,093,386        100.0

Cost of sales

     6,310,824        62.9     5,645,372        55.9
  

 

 

      

 

 

    

Gross profit

     3,715,288        37.1     4,448,014        44.1
  

 

 

      

 

 

    

Operating expenses:

          

General, administration and sales

     4,452,091        44.4     4,279,505        42.4

Research and development

     116,693        1.2     253,007        2.5
  

 

 

      

 

 

    

Total operating expenses

     4,568,784        45.6     4,532,512        44.9
  

 

 

      

 

 

    

Operating loss

     (853,496      (8.5 %)      (84,498      (0.8 %) 

Other income (expense), net

     (69,468      (0.7 %)      88,436        0.9
  

 

 

      

 

 

    

Income (loss) before income taxes

     (922,964      (9.2 %)      3,938        0.0

Provision for income taxes

     19,314        0.2     19,235        0.2
  

 

 

      

 

 

    

Net loss

   $ (942,278      (9.4 %)    $ (15,297      (0.2 %) 
  

 

 

      

 

 

    

Net Sales – Total net sales for the Company decreased $156,677, or 4.8%, to $3,082,181 for the three months ended February 28, 2019 from $3,238,858 for the three months ended February 28, 2018. Total net sales for the Company decreased $67,274, or 0.7%, to $10,026,112 for the nine months ended February 28, 2019 from $10,093,386 for the nine months ended February 28, 2018.

Balancer Segment – The Balancer segment focuses its sales efforts on end-users, rebuilders and original equipment manufacturers of grinding machines within the worldwide machine tool industry, with our primary target geographic markets being North America, Asia, and Europe.

Balancer segment sales decreased $176,175, or 8.2%, to $1,961,636 for the three months ended February 28, 2019 as compared to $2,137,811 for the three months ended February 28, 2018. The decrease in the three-month results was primarily attributed to weaker sales in Asia, which was impacted by tariffs and the pending trade negotiations between the U.S. and China, and a decrease in sales into Europe driven primarily by an OEM customer’s shift in project schedule. These decreases were offset by increased sales in North America.

Balancer segment sales increased $62,394, or 1.0%, to $6,501,448 for the nine months ended February 28, 2019 as compared to $6,439,054 for the nine months ended February 28, 2018. The increase in the nine-month results was primarily driven by stronger sales in Asia which occurred in the first half of Fiscal 2019, offset by decreased sales in the European market.

Sales by geographic markets for the Balancer segment for the three and nine months ended February 28, 2019 and 2018 were as follows:

 

     Three Months Ended
February 28,
               
     2019      2018      Variance  

North America

   $ 929,389      $ 888,238      $ 41,151        4.6

Asia

     506,294        672,431        (166,137      (24.7 %) 

Europe

     490,288        545,815        (55,527      (10.2 %) 

Other

     35,665        31,327        4,338        13.8
  

 

 

    

 

 

    

 

 

    

Total Balancer segment sales

   $ 1,961,636      $ 2,137,811      $ (176,175      (8.2 %) 
  

 

 

    

 

 

    

 

 

    

 

Page 17


Table of Contents
     Nine Months Ended
February 28,
               
     2019      2018      Variance  

North America

   $ 2,801,985      $ 2,801,118      $ 867        0.0

Asia

     2,225,387        2,049,900        175,487        8.6

Europe

     1,360,840        1,514,173        (153,333      (10.1 %) 

Other

     113,236        73,863        39,373        53.3
  

 

 

    

 

 

    

 

 

    

Total Balancer segment sales

   $ 6,501,448      $ 6,439,054      $ 62,394        1.0
  

 

 

    

 

 

    

 

 

    

The levels of demand for our Balancer products in any of these geographic markets cannot be forecasted with any certainty given current economic trends and the historical volatility experienced in this market.

Measurement Segment – The Measurement segment includes two main product lines: the Acuity product line, which includes laser-based distance measurement and dimensional sizing laser sensors; and the Xact product line, which includes ultrasonic-based remote tank monitoring products and related monitoring revenues for markets in the IoT environment.

Measurement segment sales increased $19,498, or 1.8%, to $1,120,545 for the three months ended February 28, 2019 as compared to $1,101,047 for the three months ended February 28, 2018. This increase was due to strong Acuity sales realized in the third quarter of Fiscal 2019 and increases in Xact monitoring revenues, which increased 13.4% as product previously sold was deployed and measurements began. These increases were offset by decreases in Xact product sales.

Measurement segment sales decreased $129,668, or 3.5%, to $3,524,664 for the nine months ended February 28, 2019 from $3,654,332 for the nine months ended February 28, 2018. This decrease is primarily driven by a one-time large contract in Acuity that was realized in the second quarter of Fiscal 2018 and softer sales that occurred for Acuity during the first quarter of Fiscal 2019 as compared to the same period in the prior year. This decrease was offset by the increases in Xact product sales and monitoring revenues. The increase in Xact product sales was driven by strong results experienced in the first quarter of Fiscal 2019. Xact monitoring revenues increased 15.7% in the nine months ended February 28, 2019 as compared to the same period in the prior year as product previously sold was deployed and measurements began.

Sales by product line for the Measurement segment for the three and nine months ended February 28, 2019 and 2018 were as follows:

 

     Nine Months Ended
February 28,
               
     2019      2018      Variance  

North America

   $ 2,801,985      $ 2,801,118      $ 867        0.0

Asia

     2,225,387        2,049,900        175,487        8.6

Europe

     1,360,840        1,514,173        (153,333      (10.1 %) 

Other

     113,236        73,863        39,373        53.3
  

 

 

    

 

 

    

 

 

    

Total Balancer segment sales

   $ 6,501,448      $ 6,439,054      $ 62,394        1.0
  

 

 

    

 

 

    

 

 

    

 

     Nine Months Ended
February 28,
               
     2019      2018      Variance  

Acuity

   $ 1,578,521      $ 1,905,397      $ (326,876      (17.2 %) 

Xact - product sales

     927,867        795,372        132,495        16.7

Xact - monitoring revenues

     1,004,654        868,056        136,598        15.7

Lasercheck

     0        64,140        (64,140      (100.0 %) 

SMS

     13,622        21,367        (7,745   
  

 

 

    

 

 

    

 

 

    

Total Measurement segment sales

   $ 3,524,664      $ 3,654,332      $ (129,668      (3.5 %) 
  

 

 

    

 

 

    

 

 

    

 

Page 18


Table of Contents

Gross Margin – Gross margin for the three months ended February 28, 2019 decreased to 32.8% as compared to 40.8% for the three months ended February 28, 2018. Gross margin for the nine months ended February 28, 2019 decreased to 37.1% as compared to 44.1% for the nine months ended February 28, 2018. The decreases in gross margin experienced between the periods presented were primarily influenced by efforts that occurred in the third quarter of Fiscal 2019 to evaluate the types and levels of inventory maintained across the Company’s three product lines. This resulted in a direct adjustment to cost of sales, thereby reducing gross margin from 46.1% to 32.8% for the three months ended February 28, 2019 and from 41.1% to 37.1% for the nine months ended February 28, 2019. In addition, margins were also influenced by the mix of products sold during the respective periods across the Company’s three product lines, decreases in overall product costs incurred, and the shift in SBS product sales between the European, North American and Asian markets.

Operating Expenses – Operating expenses increased $165,257, or 12.1%, to $1,527,765 for the three months ended February 28, 2019 from $1,362,508 for the three months ended February 28, 2018. These results include non-recurring reorganization and legal expenses of $292,888 incurred during the three-month period ended February 28, 2019, that are not expected to be incurred in future periods.

Other items that impacted operating expenses for the three months ended February 28, 2019 include:

 

   

Decrease in trade show expenses in the amount of $29,188, or 65.2%, due to timing of certain trade shows for our three product lines; and

 

   

Decrease in research and development expense in the amount of $55,258, or 72.9%, as a result of the shift of engineering resources towards support of existing product initiatives rather than research and development.

Operating expenses increased $36,272, or 0.8%, to $4,568,784 for the nine months ended February 28, 2019 from $4,532,512 for the nine months ended February 28, 2018. These results include non-recurring reorganization, legal and other professional expenses in the amount of $637,447 incurred during the nine-month period ended February 28, 2019, that are not expected to be incurred in future periods.

Other items that impacted operating expenses for the nine months ended February 28, 2019 include:

 

   

Decrease in commission expense in the amount of $148,131, or 20.8%, as a result of the restructuring of the Company’s sales commissions programs that occurred during Fiscal 2018;

 

   

Decrease in research and development expense in the amount of $136,314, or 53.9%, as a result of the shift of engineering resources towards support of existing product initiatives rather than research and development.

Other Income (Expense) – Other income (expense) consists of foreign currency exchange gain (loss), interest income (expense) and other income (expense). Foreign currency exchange gains were $50,725 and $58,725 for the three months ended February 28, 2019 and 2018, respectively. The shifts in the foreign currency exchange are related to significant fluctuations of foreign currencies against the U.S. dollar during the current period of Fiscal 2019. Interest income (expense), net was $(3,957) and $3,090 for the three months ended February 28, 2019 and 2018, respectively. Other income (expense) was $11 for the first quarter of Fiscal 2019 as compared to $0 for the same period in the prior year.

Foreign currency exchange gains (losses) were $(79,397) and $85,913 for the nine months ended February 28, 2019 and 2018, respectively. The shifts in the foreign currency exchange are related to significant fluctuations of foreign currencies against the U.S. dollar during the current period of Fiscal 2019. Interest income (expense), net was $9,890 and $3,122 for the nine months ended February 28, 2019 and 2018, respectively. Other income (expense) was $39 for the first half of Fiscal 2019 as compared to $(599) for the same period in the prior year.

Income Taxes – The Company’s effective tax rate on consolidated net loss was 2.1% for the nine months ended February 28, 2019. The effective tax rate on consolidated net loss differs from the federal statutory tax rate primarily due to changes in the deferred tax valuation allowance and certain expenses not being deductible for income tax reporting purposes. Management believes the effective tax rate for Fiscal 2019 will be approximately 3.2% due to the items noted above.

Net Income (Loss) – Net loss was $475,189, or $(0.12) per fully diluted share, for the three months ended February 28, 2019 as compared to net income of $15,553, or $0.00 per fully diluted share, for the three months ended February 28, 2018. Net loss was $942,278, or $(0.24) per fully diluted share, for the nine months ended February 28, 2019 as compared to net loss of $15,297, or $0.00 per fully diluted share, for the nine months ended February 28, 2018.

 

Page 19


Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

The Company’s working capital decreased $823,361 to $7,424,612 as of February 28, 2019 as compared to $8,247,973 as of May 31, 2018.

Cash, cash equivalents and restricted cash decreased $885,768 to $1,225,765 as of February 28, 2019 from $2,111,533 as of May 31, 2018. Cash used in operating activities totaled $962,266 for the nine months ended February 28, 2019 as compared to cash used in operating activities of $1,096,192 for the nine months ended February 28, 2018. The net loss of $942,278, along with slight increases in inventories and accounts receivable, primarily impacted the total cash used in operating activities for the nine months ended February 28, 2019. The changes in inventories had the largest impact on the cash used in operating activities for the nine-month period ended February 28, 2018.

At February 28, 2019, the Company had accounts receivable of $2,078,116 as compared to $2,047,032 at May 31, 2018. The increase in accounts receivable of $31,084 was due to timing of receipts. Inventories increased $40,276 to $5,751,164 as of February 28, 2019 as compared to $5,710,888 at May 31, 2018. At February 28, 2019, total current liabilities increased $53,561 to $1,823,965, as compared to $1,770,404 at May 31, 2018. The increase in current liabilities is primarily due to the timing of payments to our vendors and sales representatives and the financing of the purchase of a new accounting and operational software system and a replacement of switches for the Company’s server.

We believe that our existing cash and cash equivalents combined with the cash we anticipate generating from operating activities will be sufficient to meet our cash requirements for the foreseeable future. We do not have any significant commitments nor are we aware of any significant events or conditions that are likely to have a material impact on our liquidity or capital resources.

Risk Factors

Please refer to the risk factors disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended May 31, 2018 for a listing of factors that could cause actual results or events to differ materially from those contained in any forward-looking statements made by or on behalf of the Company.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes from the information previously reported under Item 7A of our Annual Report on Form 10-K for the fiscal year ended May 31, 2018.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of February 28, 2019, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as such term is defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”). Based on the evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Report, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and the Company’s Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives, and management necessarily is required to use its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting that occurred during the Company’s fiscal quarter ended February 28, 2019 that has materially affected, or is reasonably likely to materially affect, such internal control over financial reporting.

 

Page 20


Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

On April 1, 2019, Schmitt Industries, Inc. (the “Company”) and plaintiffs North American Satellite Corp., Insite Platform Partners, and Rick Humphreys settled the lawsuit brought by the plaintiffs on January 8, 2019. Though the terms of the settlement agreement are confidential, the settlement amount is immaterial to the Company.

Item 6. Exhibits

 

Exhibit   

Description

    3.1    Second Restated Articles of Incorporation of Schmitt Industries, Inc. [Form 10-K for the fiscal year ended May 31, 1998, Exhibit 3(i)].
    3.2    Second Restated Bylaws of Schmitt Industries, Inc. [Form 10-K for the fiscal year ended May  31, 1998, Exhibit 3(ii)].
    4.1    See Exhibits 3.1 and 3.2 for provisions of the Articles of Incorporation and Bylaws defining the rights of security holders.
  31.1    Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2    Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1    Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document.
101.SCH    XBRL Taxonomy Extension Schema Document.
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB    XBRL Taxonomy Extension Label Linkbase Document.
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document.

 

Page 21


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  SCHMITT INDUSTRIES, INC.
                  (Registrant)
Date: April 10, 2019  

/s/ Ann M. Ferguson

  Ann M. Ferguson, Chief Financial Officer and Treasurer

 

Page 22